DOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial, Rx Supply Disruption — Hospira Inc. (High Risk — Seri
DOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial, Rx Supply Disruption — Hospira Inc. (High Risk — Seri is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: DOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial, Rx; Manufacturer: Hospir
| Drug name | DOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial, Rx |
|---|---|
| Manufacturer | Hospira Inc. |
| Recall/Disruption reason | Presence of Particulate Matter: Discolored solution due to a chip in the glass at the neck of the vial, also glass parti |
| Risk classification | High Risk — Serious Health Hazard |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-1540-2014 |
| Initiation date | 20140110 |
| Quantity affected | 123,900 vials |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →